To improve the website's functionality, we use cookies, including third-party cookies. Read our Privacy Policy for more information

I Agree

Organ Preservation Solutions Market

Organ Preservation Solutions Market Analysis, By Technique (Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion), By Organ Type (Kidneys, Liver, Lungs, Heart), By End User (Organ Transplant Centers, Hospitals, Others) & Region - Global Market Insights 2027

Analysis of Organ Preservation Solutions market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Organ Preservation Solutions Market Outlook (2022-2027)

The global organ preservation solutions market currently accounts for a valuation of US$ 233 million and is anticipated to reach US$ 330 million by the end of 2027. Worldwide demand for organ preservation solutions is forecasted to accelerate at a CAGR of 7.2% from 2022 to 2027.

Demand for static cold storage techniques is predicted to increase at a higher CAGR of 7.5% through 2027. The kidneys, liver, lungs, pancreas, and heart are all preserved with these methods.

Report Attributes

Details

Organ Preservation Solutions Market Size (2022)

US$ 233 Million

Projected Market Value (2027)

US$ 330 Million

Global Market Growth Rate (2022-2027)

7.2% CAGR

Market Share of Static Cold Storage

45%

Key Companies Profiled

  • BioLife Solutions, Inc.
  • Essential Pharmaceuticals, LLC
  • Lifeline Scientific, Inc.
  • Preservation Solutions, Inc.
  • XVIVO Perfusion AB
  • Teva Pharmaceutical Industries Ltd.
  • Bridge to Life Ltd.
  • Accord Healthcare
  • OrganOx Limited
  • ToleroTech, Inc.
  • Claris Injectables Limited
  • Paragonix Technologies Inc.
  • BioTime, Inc.

Don't Need a Global Report?

Save 40% on Country & Region specific reports

Revenue Analysis of Organ Preservation Solutions (2017-2021) Vs. Market Projections (2022-2027)

“Increase in Organ Transplant Procedures Driving Demand for Organ Preservation Solutions”

According to Fact.MR, a market research and competitive intelligence provider, sales of organ preservation solutions are predicted to evolve at a CAGR of 7.2% from 2022 to 2027.

Since organs frequently collapse after being removed from the human body, organ preservation techniques are employed to safeguard organs before transplantation. Organ preservation techniques are used to keep organs safe for organ transplantation and research.

The rising rate of multi-organ failure, the ageing population, the increase in organ transplants and organ donors, and the expansion of programs to promote organ donation are the main factors driving market growth.

Rising number of persons who choose to donate their transplants and experimentation is also helping to fuel market growth. Additional elements, including increasing research and development and major advancements in the organ care systems, are predicted to have a significant impact on market growth as well.

Organ preservation solutions market forecast by Fact.MR

Organ Preservation Solutions Market

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

Which Aspects are Shaping the Path of the Organ Preservation Solutions Market?

“Constant Advancements in Organ Preservation Techniques”

Market growth is significantly fueled by technological advancements. Key companies are currently working to develop cutting-edge protection and conservation methods to combat tissue edema and organ survival before transplantation.

A promising and efficient preservation method called persufflation enhances oxygenation, which enhances grafting during preservation, protection, and transplanting. To deliver better healthcare services, governments all around the world are concentrating on bolstering their healthcare infrastructures.

Several hospitals caring for patients who are brain dead and who might be potential donors will rise as a result of these infrastructure improvements.

One of the most frequent causes of death in ICUs is multiple organ failure, which is primarily brought on by sepsis. Acute renal failure is more common in the elderly due to age-related declines in renal plasma flow and glomerular filtration rate. Diabetes makes people more susceptible to both of these diseases and multiple organ failure. Geriatric patients are more likely to have illnesses, including TB and liver cirrhosis, which may necessitate organ transplantation.

  • The Organ Procurement and Transplantation Network asserts that the increase in the number of elderly individuals undergoing organ transplants has a significant impact on the volume of organ transplantation procedures performed.

“Growing Prevalence of CKDs and Sepsis across Geographies”

Demand for organ preservation products is increased by conditions such as sepsis and chronic kidney diseases (CKDs). One of the most frequent causes of death in intensive care units is multiple organ failure, which is usually brought on by sepsis.

Sepsis is a diagnosis reaction to infection that, according to the World Health Organization (WHO), is frequently the last common pathway to mortality from many infectious illnesses globally. Sepsis incidence is difficult to determine on a global scale.

Many people don't realize they have CKDs until it is progressed since early-stage kidney infections frequently have no symptoms. Over time, kidney disease frequently gets worse, and it can cause renal failure as well as other health problems, including a heart attack or stroke. As a result, kidney failures have increased due to the rising prevalence of CKDs and sepsis, which is driving the organ preservation systems market.

To provide better healthcare services, governments all around the world are concentrating on bolstering their healthcare infrastructures. There will be more hospitals that handle more brain-dead people who might make good donors as a result of these infrastructure upgrades.

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

What Challenges are Faced by Organ Preservation Solution Providers?

“High Cost of Organ Transplant Procedures and Available Alternatives”

The market for organ preservation solutions is suffering from a decrease in the number of organ donors available for transplants involving the kidney, liver, heart, and other organs.

The gap between supply and demand is growing as the number of organ donors drops, which could impede market expansion. Due to a lack of available organ donors, surgeons are increasingly turning to artificial organs. Additionally, the demand for organ transplants is impacted by a lack of reimbursement.

High cost of organ transplant procedures, the absence of suitable donors, and available alternatives to organ transplantation, such as the development of organs with the aid of stem cell treatments are hampering market growth.

How Can New Entrants Penetrate This Market?

“Start-ups Can Focus on Developing Innovative Organ Preservation Techniques”

New entrants are engaged in investing in research and development to create advanced products. New companies are working to develop innovative organ preservation methods that will extend their shelf lives while posing fewer hazards.

  • OrganX Scientific, a start-up based in the U.S. seeks to transform organ transplantation by developing innovative novel preservation technologies. OrganX Scientific intends to commercialize its invention with active perfusion of blood through the organ while it is being transported and kept in settings that replicate the human body. This would lengthen an organ's ability to survive throughout shipment and guarantee that it stays in good shape.

Which Region Provides Optimistic Opportunities for Market Players?

“Better Reimbursement Policies in North America”

North America leads the organ preservation solutions market ascribed to many variables, including the increased demand for and use of organ transplantation as a result of the rise in chronic diseases and the rising requirement for preservation technologies to safeguard the viability of organs in ex-vivo settings.

The main drivers of market expansion in the region are the increasing acceptance of innovative medical technologies, better reimbursement policies, and rising investments in expanding healthcare infrastructure.

Country-wise Insights

Why is the U.S. a Major Market for Organ Preservation Solutions?

“Increase in Number of Patients of Alcoholic Fatty Liver Disease”

The U.S. market is anticipated to develop as a result of rising FDA approvals, the significant presence of manufacturers of organ preservation solutions, the rise in renal illnesses, and an increase in organ transplant procedures.

Due to the high number of organ transplants occurring in the country and the significant technological advancements made to perform these procedures, the market is predicted to grow quickly during the projected period.

The market has been fueled by an increase in the number of patients with alcoholic fatty liver diseases, an increase in demand for cutting-edge treatment options, and rising government investments in the development of organ preservation techniques.

How Will China Perform On a Global Scale?

“Growing Public Awareness about Organ Donation in China”

The organ preservation solutions market in China is expected to rise at a CAGR of 9% over the forecast period. The market in China is expanding as a result of factors such as an increasing geriatric population looking for better treatment options, growing public awareness about organ donation, and a supportive regulatory environment intended to enhance organ transplantation procedures.

Growing patient awareness, rising demand for lung preservation systems, rising prevalence of cardiovascular and renal disorders, and increased public and private investments are all expected to fuel market expansion.

Category-wise Insights

Which Technique Will Boost Organ Preservation Solutions Industry Growth?

“Growing Usage of Static Cold Storage for Organ Preservation”

Based on technique, the organ preservation solutions market is divided into normothermic machine perfusion, hypothermic machine perfusion, static cold storage, and others. Static cold storage accounts for 45% share of the global market due to its wide applicability.

The main purpose of static cold storage is kidney preservation. Due to the slowed kinetics of metabolic activities from the donor organ caused by the hypothermia induced in this approach, it is the most widely used and regarded as the gold standard method for organ preservation.

Additionally, it is projected that the existence of numerous market participants who provide static cold storage would foster segment expansion.

Why is Demand for Kidney Preservation Systems So High?

“Increasing Kidney Transplant Surgeries and Occurrences of Kidney Failure”

The organ preservation solutions market is segmented into liver, lungs, kidneys, heart, and others based on the organ type.

Kidney preservation systems are anticipated to contribute the largest amount of revenue due to a growth in kidney transplant surgeries and occurrences of kidney failure. It is also anticipated that several awareness initiatives highlighting the advantages of kidney transplantation will fuel market expansion.

For instance, the NHS started the "Advancing American Renal Health" initiative to improve the lives of patients with kidney diseases in the U.S.

Will Organ Transplant Centers Continue to Hold a Significant Market Share?

“Improved Medical Facilities in Organ Transplant Centers”

By end user, the organ preservation solutions market is categorized into organ transplant centers, hospitals, and specialty clinics.

The primary driver fueling the acceptance of organ transplant centers and accelerating market expansion is the rising number of transplant facilities throughout the world.

In several parts of the world, organ transplant centers offer liver and kidney preservation services. The improved medical facilities and rising success rate have made it a preferred option for transplant patients all around the world. Organ transplant centers are anticipated to continue to lead in organ preservation and transplantation over the coming years.

Competitive Landscape

Key players in the organ preservation solutions market are involved in reimbursement scenarios, the development of modern technologies, and the introduction of new products.

For instance :

  • In 2021, the LIVERguard Donor Liver Preservation System was introduced by Paragonix Technologies in the U.S. and Europe. This tactic boosted Paragonix's global presence and broadened its range of products.
  • In 2020, OrganoPlate Caco-2, an assay-ready product line was introduced by MIMETAS for organs-on-chips. 38 intestinal tubules were formed in this product while flowing against an extracellular matrix. The goal of this product's development was to make organs-on-chips technology accessible to everyone.

Organ Preservation Solutions Industry Research Segments

  • By Technique :

    • Static Cold Storage
    • Hypothermic Machine Perfusion
    • Normothermic Machine Perfusion
    • Others
  • By Organ Type :

    • Kidneys
    • Liver
    • Lungs
    • Heart
    • Others
  • By End User :

    • Organ Transplant Centers
    • Hospitals
    • Specialty Clinics
  • By Region :

    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

- Premium Report Details -

Organ Preservation Solutions Market
  • FACT7752MR
  • Oct-2022
  • Healthcare
  • 170 Pages
  • 84 Tables
  • 112 Figures

- Let's Connect -

Talk To an Expert Today Connect

- Get Started -

Get insights that lead to new growth opportunities

Buy Now

Get A Special pricing for start-ups and universities

Enquiry Before Buying

- Humble, Yet Honored -

Our prestigious clients

- Research Methodology -

An Adaptive Approach to Modern-day Research Needs

Get Methodology

- FAQs -

At present, the organ preservation solutions market is valued at US$ 233 million.

Demand for organ preservation solutions is predicted to increase at 7.2% CAGR from 2022 to 2027.

The organ preservation solutions market is estimated to reach US$ 330 million by 2027.

The market for organ preservation solutions is driven by a rise in organ transplantation, aging population, and technological advancements.

BioLife Solutions, Inc., Essential Pharmaceuticals, LLC, and Lifeline Scientific, Inc. are key players in the market.

Exclusive Report

Need An Exclusive Report For Your Unique Requirement?

Google translate